{"id":2097,"date":"2026-04-10T08:27:31","date_gmt":"2026-04-10T05:27:31","guid":{"rendered":"https:\/\/merkezlaboratuvari.com\/test-listesi\/alt-alanin-aminotransferaz-sgpt-2\/"},"modified":"2026-04-21T12:38:35","modified_gmt":"2026-04-21T09:38:35","slug":"alt-alanin-aminotransferaz-sgpt","status":"publish","type":"page","link":"https:\/\/merkezlaboratuvari.com\/ar\/test-listesi\/alt-alanin-aminotransferaz-sgpt\/","title":{"rendered":"ALT (Alanin Aminotransferaz, SGPT)"},"content":{"rendered":"<h1>ALT (Alanin Aminotransferaz, SGPT)<\/h1>\n<h2>Laboratuvar Bilgileri<\/h2>\n<ul>\n<li><strong>Yeni Kod:<\/strong> BIO4096<\/li>\n<li><strong>SUT Kodu:<\/strong> L100300<\/li>\n<li><strong>Eski Kod:<\/strong> B\u01300196<\/li>\n<li><strong>Kategori:<\/strong> \u0643\u064a\u0645\u064a\u0627\u0621 \u062d\u064a\u0648\u064a\u0629<\/li>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> Serum<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Sar\u0131 Kapak<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> Ayn\u0131 g\u00fcn 18:00<\/li>\n<\/ul>\n<h2>ALT (Alanin Aminotransferaz, SGPT) Testi Nedir?<\/h2>\n<p>ALT (Alanin Aminotransferaz, SGPT), laboratuvar ortam\u0131nda de\u011ferlendirilen bir biyokimya testidir. De\u011ferlendirme \u00e7o\u011fu zaman serum \u00f6rne\u011fi \u00fczerinden planlan\u0131r.<\/p>\n<p>ALT (Alanin Aminotransferaz), eski ad\u0131yla SGPT (Serum Glutamik Pir\u00fcvik Transaminaz), a\u011f\u0131rl\u0131kl\u0131 olarak karaci\u011fer h\u00fccrelerinde (hepatositlerde) bulunan bir enzimdir. AST&#8217;ye k\u0131yasla karaci\u011fere daha \u00f6zg\u00fcd\u00fcr. Karaci\u011fer h\u00fccre hasar\u0131 olu\u015ftu\u011funda kana sal\u0131n\u0131r ve serum d\u00fczeyi y\u00fckselir.<\/p>\n<p>Bu testin klinik anlam\u0131; istem nedeni, hastan\u0131n yak\u0131nmalar\u0131, ya\u015f\u0131, e\u015flik eden hastal\u0131klar\u0131, kullan\u0131lan y\u00f6ntem ve di\u011fer laboratuvar bulgular\u0131 ile birlikte de\u011ferlendirilir. Bu nedenle sonu\u00e7, tek ba\u015f\u0131na de\u011fil, b\u00fct\u00fcnc\u00fcl t\u0131bbi \u00e7er\u00e7eve i\u00e7inde yorumlanmal\u0131d\u0131r.<\/p>\n<h2>ALT (Alanin Aminotransferaz, SGPT) Hangi Durumlarda \u0130stenir?<\/h2>\n<p>ALT (Alanin Aminotransferaz, SGPT) testi, hekim taraf\u0131ndan klinik gereklilik g\u00f6r\u00fclen durumlarda istenebilir. \u0130stem gerek\u00e7esi hastan\u0131n mevcut tablosuna g\u00f6re de\u011fi\u015febilir.<\/p>\n<ul>\n<li>Karaci\u011fer hastal\u0131klar\u0131n\u0131n taranmas\u0131, tan\u0131s\u0131 ve takibi<\/li>\n<li>Viral hepatit (A, B, C) tan\u0131 ve izlemi<\/li>\n<li>\u0130la\u00e7 kaynakl\u0131 karaci\u011fer hasar\u0131n\u0131n izlenmesi<\/li>\n<li>Ya\u011fl\u0131 karaci\u011fer hastal\u0131\u011f\u0131 (NAFLD\/NASH) de\u011ferlendirmesi<\/li>\n<li>Alkole ba\u011fl\u0131 karaci\u011fer hasar\u0131 takibi<\/li>\n<li>Sar\u0131l\u0131k nedeninin ara\u015ft\u0131r\u0131lmas\u0131<\/li>\n<li>Rutin sa\u011fl\u0131k taramalar\u0131<\/li>\n<\/ul>\n<p>Ayn\u0131 test farkl\u0131 hastalarda farkl\u0131 klinik sorulara yan\u0131t aramak amac\u0131yla kullan\u0131labildi\u011fi i\u00e7in, nihai de\u011ferlendirme her zaman ki\u015fisel t\u0131bbi \u00f6yk\u00fc ve muayene bulgular\u0131 ile birlikte yap\u0131lmal\u0131d\u0131r.<\/p>\n<h2>ALT (Alanin Aminotransferaz, SGPT) Testi \u00d6ncesi Haz\u0131rl\u0131k<\/h2>\n<p>Haz\u0131rl\u0131k gereksinimi; testin t\u00fcr\u00fcne, numune yap\u0131s\u0131na ve laboratuvar\u0131n \u00e7al\u0131\u015fma kurallar\u0131na g\u00f6re de\u011fi\u015febilir. Test \u00f6ncesinde laboratuvar\u0131n ve hekimin verdi\u011fi talimatlar esas al\u0131nmal\u0131d\u0131r.<\/p>\n<ul>\n<li>Genellikle 8\u201312 saatlik a\u00e7l\u0131k \u00f6nerilir.<\/li>\n<li>A\u011f\u0131r fiziksel aktiviteden testten 24 saat \u00f6nce ka\u00e7\u0131n\u0131lmal\u0131d\u0131r.<\/li>\n<li>Kullan\u0131lan t\u00fcm ila\u00e7lar ve bitkisel \u00fcr\u00fcnler hekime bildirilmelidir.<\/li>\n<li>Alkol t\u00fcketimi testten en az 24 saat \u00f6nce kesilmelidir.<\/li>\n<\/ul>\n<p>Kullan\u0131lan ila\u00e7lar, takviyeler, yak\u0131n d\u00f6nemde ge\u00e7irilen hastal\u0131klar ve e\u015flik eden kronik durumlar sonucun yorumlanmas\u0131n\u0131 etkileyebilece\u011fi i\u00e7in sa\u011fl\u0131k profesyoneli ile payla\u015f\u0131lmal\u0131d\u0131r.<\/p>\n<h2>ALT (Alanin Aminotransferaz, SGPT) Testi Nas\u0131l Yap\u0131l\u0131r?<\/h2>\n<p>ALT (Alanin Aminotransferaz, SGPT) testi, uygun biyolojik \u00f6rnek al\u0131nd\u0131ktan sonra laboratuvar\u0131n belirledi\u011fi y\u00f6ntemle \u00e7al\u0131\u015f\u0131l\u0131r. Numunenin do\u011fru zamanda, uygun kapta ve uygun ta\u015f\u0131ma ko\u015fullar\u0131nda ula\u015ft\u0131r\u0131lmas\u0131 test kalitesi a\u00e7\u0131s\u0131ndan \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> Serum<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Sar\u0131 Kapak<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> Ayn\u0131 g\u00fcn 18:00<\/li>\n<\/ul>\n<ul>\n<li><strong>Numune tipi:<\/strong> Ven\u00f6z kan (serum)<\/li>\n<li><strong>Numune al\u0131m\u0131:<\/strong> Koldan ven\u00f6z kan al\u0131n\u0131r; serum ayr\u0131\u015ft\u0131r\u0131larak \u00e7al\u0131\u015f\u0131l\u0131r.<\/li>\n<li><strong>Y\u00f6ntem:<\/strong> Spektrofotometrik (kinetik UV y\u00f6ntemi, IFCC \u00f6nerisi)<\/li>\n<li><strong>Sonu\u00e7 s\u00fcresi:<\/strong> Genellikle ayn\u0131 g\u00fcn i\u00e7inde sonu\u00e7lan\u0131r.<\/li>\n<\/ul>\n<p>Baz\u0131 durumlarda \u00f6rnek kalitesi, numune miktar\u0131, ta\u015f\u0131ma s\u00fcresi veya teknik tekrar gereksinimi raporlama s\u00fcresini ve sonucun g\u00fcvenilirli\u011fini etkileyebilir.<\/p>\n<h2>ALT (Alanin Aminotransferaz, SGPT) Testi Ka\u00e7 G\u00fcnde \u00c7\u0131kar?<\/h2>\n<p>Mevcut laboratuvar bilgisine g\u00f6re bu test i\u00e7in raporlama s\u00fcresi: <strong>Ayn\u0131 g\u00fcn 18:00<\/strong> \u015feklindedir.<\/p>\n<p>Numunenin kabul zaman\u0131, laboratuvar\u0131n \u00e7al\u0131\u015fma plan\u0131, resmi tatiller veya gerekti\u011finde tekrar \u00e7al\u0131\u015fma gibi etkenler sonucu etkileyebilece\u011fi i\u00e7in en g\u00fcncel bilgi rapor tarihi \u00fczerinden de\u011ferlendirilmelidir.<\/p>\n<h2>Referans De\u011ferleri ve Sonu\u00e7lar\u0131n De\u011ferlendirilmesi<\/h2>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Grup<\/th><th>De\u011fer Aral\u0131\u011f\u0131<\/th><\/tr><\/thead><tbody><tr><td>Erkek (yeti\u015fkin)<\/td><td>7\u201356 U\/L<\/td><\/tr><tr><td>Kad\u0131n (yeti\u015fkin)<\/td><td>7\u201345 U\/L<\/td><\/tr><tr><td>Yenido\u011fan<\/td><td>13\u201345 U\/L<\/td><\/tr><tr><td>\u00c7ocuk (1\u201318 ya\u015f)<\/td><td>10\u201340 U\/L (ya\u015fa g\u00f6re de\u011fi\u015fir)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n<p>> Not: Referans de\u011ferleri laboratuvarlar ve kullan\u0131lan y\u00f6nteme g\u00f6re farkl\u0131l\u0131k g\u00f6sterebilir.<\/p>\n<p>Referans bilgileri; kullan\u0131lan y\u00f6ntem, ya\u015f grubu, biyolojik \u00f6rnek tipi ve laboratuvar standard\u0131na g\u00f6re de\u011fi\u015febilece\u011finden, rapor \u00fczerinde yer alan laboratuvar yorumu esas al\u0131nmal\u0131d\u0131r.<\/p>\n<h2>ALT (Alanin Aminotransferaz, SGPT) Sonucu Nas\u0131l Yorumlan\u0131r?<\/h2>\n<p>Test sonucu tek ba\u015f\u0131na kesin tan\u0131 koydurmaz. Sonu\u00e7; klinik bulgular, di\u011fer laboratuvar verileri ve gerekli g\u00f6r\u00fcld\u00fc\u011f\u00fcnde ek incelemeler ile birlikte de\u011ferlendirilir.<\/p>\n<h3>Y\u00fcksek ALT De\u011ferleri<\/h3>\n<ul>\n<li><strong>Hafif y\u00fckseklik (1\u20133 kat):<\/strong> Ya\u011fl\u0131 karaci\u011fer (NAFLD), kronik hepatit B veya C, ila\u00e7 etkisi, obezite, metabolik sendrom<\/li>\n<li><strong>Orta d\u00fczey y\u00fckseklik (3\u201310 kat):<\/strong> Akut viral hepatit, otoimm\u00fcn hepatit, alkolik hepatit, toksik hepatit<\/li>\n<li><strong>Belirgin y\u00fckseklik (>10 kat):<\/strong> Akut viral hepatit, ila\u00e7\/toksin kaynakl\u0131 akut karaci\u011fer hasar\u0131, iskemik hepatit<\/li>\n<li><strong>\u00c7ok y\u00fcksek de\u011ferler (>1000 U\/L):<\/strong> Akut viral hepatit, parasetamol toksisitesi, iskemik hepatit<\/li>\n<\/ul>\n<h3>D\u00fc\u015f\u00fck ALT De\u011ferleri<\/h3>\n<ul>\n<li>Klinik olarak genellikle \u00f6nem ta\u015f\u0131maz.<\/li>\n<li>Nadiren B6 vitamini eksikli\u011fi veya kronik b\u00f6brek hastal\u0131\u011f\u0131nda g\u00f6r\u00fclebilir.<\/li>\n<\/ul>\n<p>\u00d6zellikle s\u0131n\u0131rda, d\u00fc\u015f\u00fck d\u00fczeyli veya beklenmeyen sonu\u00e7larda klinik korelasyon gerekir. Gerekti\u011finde tekrar test, panel de\u011ferlendirmesi veya ek laboratuvar incelemeleri planlanabilir.<\/p>\n<h2>Testin S\u0131n\u0131rl\u0131l\u0131klar\u0131<\/h2>\n<p>Her laboratuvar testinde oldu\u011fu gibi bu incelemenin de baz\u0131 s\u0131n\u0131rl\u0131l\u0131klar\u0131 vard\u0131r. Sonu\u00e7; \u00f6rnek kalitesi, \u00f6rnekleme zaman\u0131, ta\u015f\u0131ma ko\u015fullar\u0131 ve klinik ba\u011flamdan etkilenebilir.<\/p>\n<ul>\n<li>Tek bir laboratuvar sonucu, klinik \u00e7er\u00e7eve d\u0131\u015f\u0131nda eksik yorumlanabilir.<\/li>\n<li>Uygun olmayan numune kalitesi sonucun g\u00fcvenilirli\u011fini azaltabilir.<\/li>\n<li>Gerekti\u011finde ek testler olmadan tek ba\u015f\u0131na karar vermek yan\u0131lt\u0131c\u0131 olabilir.<\/li>\n<\/ul>\n<h2>Olas\u0131 Riskler<\/h2>\n<p>Risk \u00e7o\u011funlukla numune alma ve numune y\u00f6netimi s\u00fcreci ile ili\u015fkilidir. Testin kendisinden \u00e7ok, \u00f6rne\u011fin al\u0131nmas\u0131 ve uygun ko\u015fullarda \u00e7al\u0131\u015f\u0131lmas\u0131 \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li>ALT, AST&#8217;ye g\u00f6re karaci\u011fere daha \u00f6zg\u00fc bir enzimdir; ancak tek ba\u015f\u0131na tan\u0131 koydurmaz.<\/li>\n<li>Obezite ve metabolik sendromda ALT hafif y\u00fcksek olabilir.<\/li>\n<li>Baz\u0131 ila\u00e7lar (statinler, NSA\u0130\u0130&#8217;ler, antibiyotikler, antiepileptikler, parasetamol) ALT y\u00fcksekli\u011fine neden olabilir.<\/li>\n<li>AST, GGT, ALP, bilirubin ve albumin gibi di\u011fer karaci\u011fer testleriyle birlikte de\u011ferlendirilmelidir.<\/li>\n<li>Hemolizli numuneler yanl\u0131\u015f sonu\u00e7lara yol a\u00e7abilir.<\/li>\n<li>Kas hasar\u0131nda da hafif y\u00fckselebilir, ancak bu durumda AST ve CK daha belirgin y\u00fckselir.<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>ALT (Alanin Aminotransferaz, SGPT) Laboratuvar Bilgileri Yeni Kod: BIO4096 SUT Kodu: L100300 Eski Kod: B\u01300196 Kategori: Biyokimya Numune T\u00fcr\u00fc: Serum Numune Kab\u0131: Sar\u0131 Kapak \u00c7al\u0131\u015fma G\u00fcn\u00fc: Her g\u00fcn \u00d6nemli Kriter: \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r. Raporlama Tarihi: Ayn\u0131 g\u00fcn 18:00 ALT (Alanin Aminotransferaz, SGPT) Testi Nedir? ALT (Alanin [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"parent":5,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"test_category":"Biyokimya","test_kodu":"BIO4096","numune_turu":"Serum","numune_kabi":"Sar\u0131 Kapak","calisma_gunu":"Her g\u00fcn","onemli_kriter":"\u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.","raporlama_tarihi":"Ayn\u0131 g\u00fcn 18:00","numune_red_kriterleri":"","aktarim_kodu":"","loinc_kodu":"","sut_kodu":"L100300","akredite":"","numune_miktari":"","alternatif_ornek":"","numune_alinma_sekli":"","stabilite_ozellikleri":"","calisma_yontemi":"","test_bilgisi":"","footnotes":""},"class_list":["post-2097","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2097","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/types\/page"}],"replies":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/comments?post=2097"}],"version-history":[{"count":5,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2097\/revisions"}],"predecessor-version":[{"id":8908,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2097\/revisions\/8908"}],"up":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/5"}],"wp:attachment":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/media?parent=2097"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}